Nov 11, 2022, 11:04 by

Adding increased bioavailability excipients in drug formulations has gained widespread attention because they can alter the pharmacokinetics of drugs, ultimately resulting in improved bioavailability.

Nov 11, 2022, 11:04 by

As versatile materials that possess modulable frameworks based on cross-linked copolymers, ion exchange resins reserve functional groups to attract ions of opposite charges and thus are broadly utilized in the separation application.

Nov 11, 2022, 10:37 by

With the aid of artificial intelligence and AI-based sophisticated machine learning technology, data processing has become much easier, which greatly eases burdens for researchers,” said a senior scientist from Alfa Chemistry.

Nov 11, 2022, 10:36 by

Nov 11, 2022, 10:22 by

Nov 11, 2022, 10:21 by

Invests in a new high speed filling line for pre-filled syringes and cartridges at its facility in Wasserburg.

Nov 11, 2022, 10:16 by

Nov 11, 2022, 01:00 by User Not Found

Clinical Research News | The worldwide population is aging, and the prevalence of many diseases is on the rise, making rapid drug discovery and approval ever more critical. However, the cost of bringing a new drug to market is substantial. Using newer technologies, drug companies may be able to reduce costs associated with development and ultimately enhance their odds of successful approvals by improving the efficiency of clinical trials.

Nov 10, 2022, 10:06 by

Genomics England, The British Society for Genetic Medicine (BSGM) and the Association of Genetic Nurses and Counsellors, are all joining forces to celebrate the expertise of genetic counsellors on Genetic Counsellor Awareness Day — Thursday 10 November 2022.

Nov 10, 2022, 10:05 by

Dr. Pipas’ Experience Enhances Rho’s Oncology Capabilities

Nov 9, 2022, 09:33 by

PCR Biosystems has launched a new family of qPCR reagents mixes: Clara™ Probe Mix, Clara™ Probe 1-Step Mix and Clara™ HRM Mix.

Nov 9, 2022, 09:33 by

Nov 9, 2022, 09:30 by

Nov 9, 2022, 01:00 by User Not Found

Clinical Research News | An open-source computer platform developed at Dana-Farber Cancer Institute is adding ease and speed to the process of matching cancer patients to trials of therapies targeting genomic alterations. The matching tool, which links individual clinical and genomic information to trial eligibility data in real time, is designed to help overcome the stubbornly low precision medicine trial participation rate despite more common use of genomic profiling.

Nov 8, 2022, 09:50 by

Intelligent functionality removes supply team burdens while ensuring drug availability and reducing waste

Nov 7, 2022, 10:36 by

A new tool has been developed to identify those diabetes patients who are at risk of developing Chronic Kidney Disease. Early diagnosis can lead to earlier treatment and save lives.

Nov 7, 2022, 10:32 by

The Synthetic Biology Platform is designed to program comprehensive biosynthesis development in one place.

Nov 7, 2022, 10:31 by

BOC Sciences can take care of the PROTAC in vivo evaluation workload for clients with a transparent project process and comprehensive evaluation reports to facilitate PROTAC discovery and development programs prior to clinical trials.

Nov 4, 2022, 11:17 by

Nov 4, 2022, 11:16 by